Results from a randomised, Phase II study involving 111 patients showed the proportion of metastatic breast cancer patients without tumor progression at six months was 61.1% for those
The PEARL 3 study was part of an extensive worldwide clinical development program involving more than 2,900 subjects, which evaluated the safety and efficacy of Latuda. In this
Under the terms of this agreement, Bayer will provide clinical samples, sourced from clinical studies, and Prometheus will perform mutational analyses that characterise the presence or absence of
CRi develops and markets optical imaging systems to advance biomedical research and molecular-based drug and diagnostic development. CRi’s patented preclinical and tissue-based multiplexed analysis systems will expand Caliper‘s
Lotus‘ operating entity, Beijing Liang Fang Pharmaceutical, purchased the land-use rights for the property in 2008. Lotus had originally intended to build a pharmaceutical manufacturing and storage facility
Ness will succeed Allen Allen, the current chairman, president and CEO. During the past 25 years Ness has held various C level positions in both domestic, public, private
BEMA Buprenorphine utilises BDSI’s proprietary BioErodible MucoAdhesive (BEMA) drug delivery technology, which consists of a small, dissolvable, polymer film for application to the buccal mucosa to deliver the
As per the agreement, GP Pharm Mexico will be responsible for gaining regulatory approval in Mexico for Ampligen, an experimental therapeutic, to treat Chronic Fatigue Syndrome (CFS) in
Cambridge Research & Instrumentation develops and markets optical imaging systems to advance biomedical research and molecular-based drug and diagnostic development. CRi’s patented preclinical and tissue-based multiplexed analysis systems
The deal covers the installation, training and use of Sloning’s technology platform Slonomics for fabrication of highly-diverse gene and protein libraries at Pfizer’s subsidiary Rinat Neuroscience. Under the
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.